H.R. 124

Summary

H.R. 124, the Byron Nash Renal Medullary Carcinoma Awareness Act of 2023, was introduced in the House on Jan 3, 2025 by Rep. Al Green (D). It was referred to Energy And Commerce, and last saw action on Jan 3, 2025: Referred to the House Committee on Energy and Commerce.

Record

Text

H.R. 124 has no co-sponsors and has not gone to a roll call.

119 HR 124 IH: Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
 U.S. House of Representatives
 2023-01-09
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 124  IN THE HOUSE OF REPRESENTATIVES   January 3, 2025   Mr. Green of Texas  introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.
1.
Short title
This Act may be cited as the   Byron Nash Renal Medullary Carcinoma Awareness Act of 2023  .
2.
Providing incentives for education on risk of renal medullary carcinoma to individuals with Sickle Cell Disease under Medicaid
(a)
In general
Section 1903(a)(3)(E)(ii) of the Social Security Act ( 42 U.S.C. 1396b(a)(3)(E)(ii) ) is amended by inserting  , renal medullary carcinoma,  after  stroke  each place it appears.
(b)
Effective date
The amendments made by subsection (a) shall apply with respect to items and services furnished on or after the date of the enactment of this Act.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Sponsors

Rep. Al Green (D) sponsors H.R. 124 alone.

Al Green

Rep. · D–TX-9 · Sponsor

Show 1 of 1 row

PreviousNext

Committees

H.R. 124 went before 1 committee: Energy and Commerce.

Energy and Commerce

Energy and Commerce

Referred To · Jan 3, 2025 · 1,636 Bills

Actions

H.R. 124 has taken 2 actions since Jan 3, 2025.

Votes

H.R. 124 has not gone to a roll call.

Titles

H.R. 124 goes by 3 titles, 1 of them short titles.

• Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 — Display Title
• Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 — Short Title(s) as Introduced
• To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease. — Official Title as Introduced

Classification

The Congressional Research Service files H.R. 124 under Health, one of its 31 policy areas, and gives it 4 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 124’s is Health.

Legislative Subjects

H.R. 124 carries 4 of CRS’s legislative subjects, from Cancer to Medicaid.

Source: congress.gov · legiscan.com